Aslan Pharmaceuticals Ltd Stock Buy Hold or Sell Recommendation
| ASLN Stock | USD 0.46 0.05 9.80% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Aslan Pharmaceuticals Ltd is 'Strong Sell'. Macroaxis provides Aslan Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ASLN positions. The advice algorithm takes into account all of Aslan Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Aslan Pharmaceuticals' buy or sell advice are summarized below:
Real Value 4.26 | Hype Value 0.43 | Market Value 0.46 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Aslan Pharmaceuticals Ltd given historical horizon and risk tolerance towards Aslan Pharmaceuticals. When Macroaxis issues a 'buy' or 'sell' recommendation for Aslan Pharmaceuticals Ltd, the advice is generated through an automated system that utilizes algorithms and statistical models.
Aslan |
Execute Aslan Pharmaceuticals Buy or Sell Advice
The Aslan recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Aslan Pharmaceuticals Ltd. Macroaxis does not own or have any residual interests in Aslan Pharmaceuticals Ltd or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Aslan Pharmaceuticals' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Extremely Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Aslan Pharmaceuticals Trading Alerts and Improvement Suggestions
| Aslan Pharmaceuticals is way too risky over 90 days horizon | |
| Aslan Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Aslan Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| Aslan Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 12 M. Net Loss for the year was (44.22 M) with profit before overhead, payroll, taxes, and interest of 79.82 M. | |
| Aslan Pharmaceuticals Ltd currently holds about 78.12 M in cash with (46.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.12, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Aslan Pharmaceuticals has a frail financial position based on the latest SEC disclosures |
Aslan Pharmaceuticals current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Aslan analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Aslan analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Aslan Pharmaceuticals Returns Distribution Density
The distribution of Aslan Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Aslan Pharmaceuticals' future price movements. The chart of the probability distribution of Aslan Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use Aslan Pharmaceuticals Ltd price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Aslan Pharmaceuticals returns is essential to provide solid investment advice for Aslan Pharmaceuticals.
| Mean Return | 1.74 | Value At Risk | -12.77 | Potential Upside | 23.08 | Standard Deviation | 23.83 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Aslan Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Aslan Pharmaceuticals Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aslan Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aslan Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aslan stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 1.90 | |
β | Beta against NYSE Composite | -2.06 | |
σ | Overall volatility | 23.83 | |
Ir | Information ratio | 0.07 |
Aslan Pharmaceuticals Volatility Alert
Aslan Pharmaceuticals Ltd is showing large volatility of returns over the selected time horizon. Aslan Pharmaceuticals Ltd is a potential penny stock. Although Aslan Pharmaceuticals may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Aslan Pharmaceuticals Ltd. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Aslan instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Aslan Pharmaceuticals Fundamentals Vs Peers
Comparing Aslan Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aslan Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Aslan Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aslan Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Aslan Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Aslan Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Aslan Pharmaceuticals to competition |
| Fundamentals | Aslan Pharmaceuticals | Peer Average |
| Return On Equity | -4.27 | -0.31 |
| Return On Asset | -0.64 | -0.14 |
| Operating Margin | (3.64) % | (5.51) % |
| Current Valuation | 295.2 M | 16.62 B |
| Shares Outstanding | 22.63 M | 571.82 M |
| Shares Owned By Insiders | 0.05 % | 10.09 % |
| Shares Owned By Institutions | 15.48 % | 39.21 % |
| Number Of Shares Shorted | 116.78 K | 4.71 M |
| Price To Earning | (11.50) X | 28.72 X |
| Price To Book | 2.14 X | 9.51 X |
| Price To Sales | 0.94 X | 11.42 X |
| Revenue | 12 M | 9.43 B |
| Gross Profit | 79.82 M | 27.38 B |
| EBITDA | (43.39 M) | 3.9 B |
| Net Income | (44.22 M) | 570.98 M |
| Cash And Equivalents | 78.12 M | 2.7 B |
| Cash Per Share | 1.12 X | 5.01 X |
| Total Debt | 26.83 M | 5.32 B |
| Debt To Equity | 1.12 % | 48.70 % |
| Current Ratio | 6.97 X | 2.16 X |
| Book Value Per Share | (0.76) X | 1.93 K |
| Cash Flow From Operations | (46.36 M) | 971.22 M |
| Short Ratio | 0.05 X | 4.00 X |
| Earnings Per Share | (2.75) X | 3.12 X |
| Target Price | 9.5 | |
| Number Of Employees | 35 | 18.84 K |
| Beta | 1.47 | -0.15 |
| Market Capitalization | 11.58 M | 19.03 B |
| Total Asset | 24.63 M | 29.47 B |
| Retained Earnings | (321.07 M) | 9.33 B |
| Working Capital | 11.02 M | 1.48 B |
| Current Asset | 54.61 M | 9.34 B |
| Current Liabilities | 5.15 M | 7.9 B |
Aslan Pharmaceuticals Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Aslan . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Aslan Pharmaceuticals Buy or Sell Advice
When is the right time to buy or sell Aslan Pharmaceuticals Ltd? Buying financial instruments such as Aslan Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Aslan Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sports Thematic Idea Now
Sports
Companies in sporting activities arena as well as manufacturers of sporting goods and sport retailers. The Sports theme has 25 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sports Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Aslan Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Aslan Stock analysis
When running Aslan Pharmaceuticals' price analysis, check to measure Aslan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aslan Pharmaceuticals is operating at the current time. Most of Aslan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aslan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aslan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aslan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges |
Is Aslan Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aslan Pharmaceuticals. If investors know Aslan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aslan Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aslan Pharmaceuticals is measured differently than its book value, which is the value of Aslan that is recorded on the company's balance sheet. Investors also form their own opinion of Aslan Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Aslan Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aslan Pharmaceuticals' market value can be influenced by many factors that don't directly affect Aslan Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aslan Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aslan Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aslan Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.